Micro Therapeutics Inc Watch

from 8-K 6 pages Promissory Note

from 8-K 51 pages Lease (Single Tenant; Net) Between the Irvine Company and Micro Therapeutics, Inc. Index to Lease

from 8-K 1 page Name of Executive Title Earl Slee Vice President, Research and Development William Dippel Vice President, Operations Amy Walters Vice President, Clinical, Regulatory, Quality Assurance Thomas Fogarty Vice President, Sales and Marketing

from 8-K 11 pages Form of Letter Agreement

from 8-K 13 pages Contribution and Exchange Agreement

from 8-K 2 pages First Amendment to Amended and Restated Sales Representative Agreement

from 10KSB 1 page March 28, 2005 CC: Eric Parnes, Pricewaterhouse Coopers, Llp Hal Hurwitz, Micro Therapeutics, Inc. Thomas E. Timbie, Ev3, Inc

from 10KSB 16 pages Master Services Agreement

from 8-K 3 pages Micro Therapeutics Executive Incentive Compensation Plan

from 8-K 8 pages Separation and Consulting Agreement

from 10QSB 3 pages June 30, 2004 1. Your Title Will Be Vice President, Operations and You Will Report Directly to Me. Your Duties and Responsibilities Will Include: • Provide Direction for Operations of the Manufacturing, Manufacturing Engineering, Purchasing, Warehousing, Inventory Control, Product Distribution and Overall Facilities. • Plan, Direct and Control Production and Related Support Functions to Provide High Quality Product in a Cost Effective Manner to Support the Company’s Sales Plan. • Contribute to the Overall Strategy of the Company as a Member of the Senior Management Team. Responsibility for Other Areas of the Company’s Business May Be Assigned to You as the Company Deems Necessary. 2. Your Full Time Employment Shall Begin on a Date Still to Be Determined

from 8-K ~10 pages Letter Agreement, Dated October 8, 2004

from 10QSB 13 pages Confidential Portions Have Been Omitted Based Upon a Request for Confidential Treatment Pursuant to Rule 24b-2 of the Securities Exchange Act of 1934 and Have Been Separately Filed With the Commission. Amended and Restated Sales Representative Agreement

from 10QSB 7 pages Confidential Portions Have Been Omitted Based Upon a Request for Confidential Treatment Pursuant to Rule 24b-2 of the Securities Exchange Act of 1934 and Have Been Separately Filed With the Commission. Distribution Support Services Agreement

from 10QSB 11 pages Confidential Portions Have Been Omitted Based Upon a Request for Confidential Treatment Pursuant to Rule 24b-2 of the Securities Exchange Act of 1934 and Have Been Separately Filed With the Commission. Distribution Agreement

from 10QSB 11 pages Confidential Portions Have Been Omitted Based Upon a Request for Confidential Treatment Pursuant to Rule 24b-2 of the Securities Exchange Act of 1934 and Have Been Separately Filed With the Commission. Distribution Agreement

from 10QSB 11 pages Confidential Portions Have Been Omitted Based Upon a Request for Confidential Treatment Pursuant to Rule 24b-2 of the Securities Exchange Act of 1934 and Have Been Separately Filed With the Commission. Distribution Agreement

from 10QSB 2 pages First Amendment to Lease

from 10QSB 9 pages Distribution Support Services Agreement

from 10KSB 9 pages Micro Therapeutics, Inc. Third Amended and Restated Employee Stock Purchase Plan